EUVIMEDTutustu EUVIMEDiin
Crossref

Management of Malignant Salivary Gland Tumors: A 20‐Year SEER Database Analysis

Christopher Stewart iD, J B Eyring, Braxton Felix, Karson Ballard, Chi Pham, Brandy Gotti, Alex Otto, Scott McClintick, Kent McIntire

Otolaryngology–Head and Neck Surgery · 2026-08-17

DOI: 10.1002/ohn.70375 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, published online on 2026-08-17. Written by Christopher Stewart and 8 co-authors. Institution: School of Medicine, Joplin, USA. 13 references.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Objective

Malignant salivary gland tumors represent a heterogeneous group of neoplasms with variable management. This study evaluated trends in therapeutic approaches to these cancers to inform evidence‐based, personalized care and optimize patient outcomes. Study Design Retrospective cohort study.

Setting

Population‐based analysis using the Surveillance, Epidemiology, and End Results (SEER) database.

Methods

Cases of malignant salivary gland tumors diagnosed between 2000 and 2021 were categorized by treatment modality and stage at diagnosis. Trends over time were assessed using JoinPoint segmented log‐linear regression.

Results

A total of 24,029 patients were included. Surgery alone (36.3%) and surgery with adjuvant radiation (36.5%) comprised the majority of treatments. Chemotherapy alone increased significantly over time (annual percent change [APC] +5.81%; 95% CI, 3.46‐9.24; P < .05), though it remained infrequently used. Combined modalities including surgery, chemotherapy, and radiation also showed modest growth over the study period. Stage analysis revealed increasing proportions of localized and regional tumors and a decline in distant disease.

Conclusion

Surgery remains the cornerstone of malignant salivary gland tumor management, but use of combined treatment approaches is rising, likely reflecting advances in systemic therapies and radiation techniques. Awareness of these trends is critical for guiding multidisciplinary, personalized care. Future studies integrating clinical outcomes and histologic subtype are warranted to clarify the role of expanding systemic and combined modalities.

Subjects

Author keywords

SEER databasehead and neck cancerpopulation‐based analysissalivary gland neoplasmstreatment trends

Authors and institutions

  • School of Medicine, Joplin, USA.
  • Department of Otolaryngology Head and Neck Surgery, Salt Lake City, USA.
  • Department of Otolaryngology Head and Neck Surgery, Joplin, USA.

ORCID profiles: Christopher Stewart

Cite

APA

Stewart, C., Eyring, J. B., Felix, B., Ballard, K., Pham, C., Gotti, B., Otto, A., McClintick, S., & McIntire, K. (2026). Management of Malignant Salivary Gland Tumors: A 20‐Year SEER Database Analysis. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70375

Vancouver

Stewart C, Eyring JB, Felix B, Ballard K, Pham C, Gotti B, et al. Management of Malignant Salivary Gland Tumors: A 20‐Year SEER Database Analysis. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70375

BibTeX
@article{Stewart2026,
  author = {Stewart, Christopher and Eyring, J B and Felix, Braxton and Ballard, Karson and Pham, Chi and Gotti, Brandy and Otto, Alex and McClintick, Scott and McIntire, Kent},
  title = {Management of Malignant Salivary Gland Tumors: A 20‐Year SEER Database Analysis},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  doi = {10.1002/ohn.70375}
}
Start for free →